Effect of accurate heart delineation on cardiac dose during the CONVERT Trial.
Groom, N Wilson, E Faivre-Finn, Corinne
Groom, N
Wilson, E
Faivre-Finn, Corinne
Citations
Altmetric:
Abstract
This study investigates the effect of deviation from protocol in heart delineation for the CONVERT Trial ( ClinicalTrials.gov Identifier NCT00433563) quality assurance (QA) programme, and the effect of that on mean cardiac dose and percentage of heart volume receiving ≥5Gy (V5%) and ≥30Gy (V30%).
Authors
Affiliation
Description
Date
2017-03-31
Publisher
Collections
Keywords
Type
Article
Citation
Effect of accurate heart delineation on cardiac dose during the CONVERT Trial. 2017, Br J Radiol